Chances Of Getting Neuroendocrine Carcinoma

One of the most aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that more often than not it is detected late into the advanced stages when it is extremely hard to curb it and treat it.

As the symptoms of neuroendocrine colon cancer become visible only at very advanced stages, the survival rate drops at an alarming rate. The tumors are always malignant, and mostly detected with distant metastases. Most recent surveys show that reports tell us that in almost all cases of neuroendocrine cancer ends in death.

Though chances of neuroendocrine carcinoma in colon are extremely unlikely, if one is affected the patient’s condition becomes much worse than patients who suffer from adenocarcinoma.

Research reveals that the end results of this cancer do not change with age, sex or tumor location. However, neuroendocrine colon carcinoma will depend heavily on the tumor’s stage. Standard cases have revealed that people in stage 1 and 2 of cancer will generally not experience  neuroendocrine colon cancer. But alternately in many cases when the tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.

Sadly, medical science has very few methods to treat this kind of cancer. A more common technique that doctors regularly use is immunohistochemical staining methods. This method helps the doctors to detect the seriousness of neuroendocrine colon cancer and really helps determine the most helpful medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of the tumor with the antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and the extent of damage on the health of the patient.

Neuroendocrine colon carcinoma is hard to treat and in a case study in which a number of patients suffered from this particular disease were examined, it was observed that the overall survival rate for this disease was only about seven months. While in a predominant stage, these rates drop to less than five months The great majority of these cases were at first found to be as carcinoids but they soon became in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not always a perfect or even viable treatment so surgery may not even provide a satisfactory cure. So this makes it important to detect this disease as soon as possible and prescribe the right medication.